DK0942911T3 - Benzopyranopyrroler og benzopyranopyridiner med alfa-1-adrenerg virkning - Google Patents
Benzopyranopyrroler og benzopyranopyridiner med alfa-1-adrenerg virkningInfo
- Publication number
- DK0942911T3 DK0942911T3 DK97951555T DK97951555T DK0942911T3 DK 0942911 T3 DK0942911 T3 DK 0942911T3 DK 97951555 T DK97951555 T DK 97951555T DK 97951555 T DK97951555 T DK 97951555T DK 0942911 T3 DK0942911 T3 DK 0942911T3
- Authority
- DK
- Denmark
- Prior art keywords
- alpha
- benzopyranopyrrols
- benzopyranopyridines
- adrenergic activity
- bph
- Prior art date
Links
- FULCMGRANBCDAK-UHFFFAOYSA-N 10h-chromeno[3,2-b]pyridine Chemical class C1=CN=C2CC3=CC=CC=C3OC2=C1 FULCMGRANBCDAK-UHFFFAOYSA-N 0.000 title 1
- 230000001800 adrenalinergic effect Effects 0.000 title 1
- UVFMLHRWOVHDDI-UHFFFAOYSA-N chromeno[3,2-b]pyrrole Chemical class O1C2=CC=C[CH]C2=CC2=C1C=C[N]2 UVFMLHRWOVHDDI-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000000951 adrenergic alpha-1 receptor antagonist Substances 0.000 abstract 1
- 239000000674 adrenergic antagonist Substances 0.000 abstract 1
- 102000030619 alpha-1 Adrenergic Receptor Human genes 0.000 abstract 1
- 108020004102 alpha-1 Adrenergic Receptor Proteins 0.000 abstract 1
- 230000003042 antagnostic effect Effects 0.000 abstract 1
- 125000002618 bicyclic heterocycle group Chemical group 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pyrane Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US76142396A | 1996-12-06 | 1996-12-06 | |
| US08/980,130 US6046207A (en) | 1996-12-06 | 1997-11-26 | Benzopyranopyrrole and benzopyranopyridine α-1 adrenergic compounds |
| PCT/US1997/022279 WO1998024791A1 (en) | 1996-12-06 | 1997-12-04 | Benzopyranopyrrole and benzopyranopyridine alpha-1 adrenergic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0942911T3 true DK0942911T3 (da) | 2002-12-02 |
Family
ID=27116981
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK97951555T DK0942911T3 (da) | 1996-12-06 | 1997-12-04 | Benzopyranopyrroler og benzopyranopyridiner med alfa-1-adrenerg virkning |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0942911B1 (da) |
| JP (1) | JP2002504088A (da) |
| KR (1) | KR20000057418A (da) |
| CN (1) | CN1130365C (da) |
| AT (1) | ATE207071T1 (da) |
| AU (1) | AU735764B2 (da) |
| BG (1) | BG63975B1 (da) |
| CA (1) | CA2272330A1 (da) |
| CY (1) | CY2260B1 (da) |
| CZ (1) | CZ194499A3 (da) |
| DE (1) | DE69707497T2 (da) |
| DK (1) | DK0942911T3 (da) |
| ES (1) | ES2168682T3 (da) |
| NO (1) | NO992661L (da) |
| NZ (1) | NZ335711A (da) |
| PT (1) | PT942911E (da) |
| SK (1) | SK283580B6 (da) |
| TR (1) | TR199901883T2 (da) |
| WO (1) | WO1998024791A1 (da) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001519423A (ja) * | 1997-10-10 | 2001-10-23 | アボット・ラボラトリーズ | 置換ピラジン化合物の調製方法 |
| TW536402B (en) | 1998-06-26 | 2003-06-11 | Yamanouchi Pharma Co Ltd | Pharmaceutical composition for the therapy of voiding dysfunction |
| UA69420C2 (uk) * | 1998-10-06 | 2004-09-15 | Янссен Фармацевтика Н.В. | ТРИЦИКЛІЧНІ <font face="Symbol">D3</font>-ПІПЕРИДИНИ ЯК <font face="Symbol">a<sub></font>2</sub>-АНТАГОНІСТИ |
| CA2346082C (en) * | 1998-10-06 | 2010-02-16 | Janssen Pharmaceutica N.V. | Tricyclic .delta.3-piperidines as pharmaceuticals |
| US6172260B1 (en) | 1998-12-31 | 2001-01-09 | Eastman Kodak Company | Preparation of high dye-yield couplers and intermediates useful therein |
| TWI274750B (en) | 1999-01-12 | 2007-03-01 | Abbott Gmbh & Co Kg | Triazole compounds showing high affinity to dopamine D3 receptor and pharmaceutical composition comprising the same |
| JP2001288115A (ja) * | 2001-02-07 | 2001-10-16 | Yamanouchi Pharmaceut Co Ltd | 下部尿路症治療剤 |
| US20060128719A1 (en) * | 2004-12-13 | 2006-06-15 | Boehringer Ingelheim Pharmaceuticals, Inc. | Use of alpha-adrenergic blockers for the treatment of dysmenorrhea |
| WO2020081624A1 (en) * | 2018-10-17 | 2020-04-23 | Austin Research Labs, Corp. | Suspension formulations of high load dispersions |
| CN110759878B (zh) * | 2019-10-29 | 2021-04-09 | 西安瑞联新材料股份有限公司 | 一种苯基四氢呋喃醚类化合物的合成方法 |
| WO2023248964A1 (ja) * | 2022-06-21 | 2023-12-28 | クミアイ化学工業株式会社 | ハロ酢酸を用いたスルホン誘導体の製造方法 |
| CN116768837A (zh) * | 2023-06-13 | 2023-09-19 | 常州大学 | 一种基于苯并吡喃-2-酮的荧光化学传感器及其制备方法和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3888946A (en) * | 1971-03-17 | 1975-06-10 | Little Inc A | Pyrano benzopyrans |
| US4117140A (en) * | 1975-02-10 | 1978-09-26 | Brown Richard E | Bronchodilating piperidinoethyl benzopyranopyridinones |
| AU560459B2 (en) * | 1982-06-01 | 1987-04-09 | Abbott Laboratories | Tetrahydro-benzo(e) isoindolines |
| FR2687146B1 (fr) * | 1992-02-12 | 1994-04-01 | Adir Cie | Nouveaux derives de pyrrolidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
-
1997
- 1997-12-04 CA CA002272330A patent/CA2272330A1/en not_active Abandoned
- 1997-12-04 AU AU55169/98A patent/AU735764B2/en not_active Ceased
- 1997-12-04 TR TR1999/01883T patent/TR199901883T2/xx unknown
- 1997-12-04 KR KR1019990704990A patent/KR20000057418A/ko not_active Ceased
- 1997-12-04 JP JP52581498A patent/JP2002504088A/ja active Pending
- 1997-12-04 ES ES97951555T patent/ES2168682T3/es not_active Expired - Lifetime
- 1997-12-04 EP EP97951555A patent/EP0942911B1/en not_active Expired - Lifetime
- 1997-12-04 DK DK97951555T patent/DK0942911T3/da active
- 1997-12-04 CZ CZ991944A patent/CZ194499A3/cs unknown
- 1997-12-04 WO PCT/US1997/022279 patent/WO1998024791A1/en not_active Ceased
- 1997-12-04 DE DE69707497T patent/DE69707497T2/de not_active Expired - Fee Related
- 1997-12-04 NZ NZ335711A patent/NZ335711A/xx unknown
- 1997-12-04 AT AT97951555T patent/ATE207071T1/de not_active IP Right Cessation
- 1997-12-04 PT PT97951555T patent/PT942911E/pt unknown
- 1997-12-04 CN CN97181622A patent/CN1130365C/zh not_active Expired - Lifetime
- 1997-12-04 SK SK717-99A patent/SK283580B6/sk unknown
-
1999
- 1999-06-02 NO NO992661A patent/NO992661L/no not_active Application Discontinuation
- 1999-07-05 BG BG103553A patent/BG63975B1/bg unknown
-
2002
- 2002-02-12 CY CY0200010A patent/CY2260B1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ335711A (en) | 2000-10-27 |
| JP2002504088A (ja) | 2002-02-05 |
| ATE207071T1 (de) | 2001-11-15 |
| EP0942911A1 (en) | 1999-09-22 |
| CY2260B1 (en) | 2003-07-04 |
| SK283580B6 (sk) | 2003-09-11 |
| AU735764B2 (en) | 2001-07-12 |
| AU5516998A (en) | 1998-06-29 |
| NO992661L (no) | 1999-07-30 |
| DE69707497D1 (de) | 2001-11-22 |
| KR20000057418A (ko) | 2000-09-15 |
| CA2272330A1 (en) | 1998-06-11 |
| DE69707497T2 (de) | 2002-07-11 |
| BG103553A (en) | 2000-06-30 |
| TR199901883T2 (xx) | 1999-12-21 |
| CZ194499A3 (cs) | 1999-11-17 |
| BG63975B1 (bg) | 2003-08-29 |
| ES2168682T3 (es) | 2002-06-16 |
| PT942911E (pt) | 2002-04-29 |
| CN1130365C (zh) | 2003-12-10 |
| CN1246861A (zh) | 2000-03-08 |
| WO1998024791A1 (en) | 1998-06-11 |
| EP0942911B1 (en) | 2001-10-17 |
| NO992661D0 (no) | 1999-06-02 |
| SK71799A3 (en) | 2000-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0808318T3 (da) | Tricykliske, substituerede hexahydrobenz[e]isoindol-alfa-1-adrenerge antagonister | |
| MX9705675A (es) | Antagonistas alfa-1-adrenergicos de hexahidrobenz[e]isoindol sustituidos biciclicos. | |
| DK0942911T3 (da) | Benzopyranopyrroler og benzopyranopyridiner med alfa-1-adrenerg virkning | |
| DK20987D0 (da) | Peptidylaminodioler og fremgangsmaade til deres fremstilling | |
| DE69533174D1 (de) | Pyridopyrimidinone, chinoline und anellierte n-heterozyklen als bradykinin-antagonisten | |
| DE69831937D1 (de) | Bicyclische protein-farnesyl-transferase inhibitoren | |
| ES8801245A1 (es) | Un procedimiento para preparar derivados de piperidina | |
| PT78064A (en) | Process for preparing benzazocinone and benzazoninone derivatives | |
| MX9806171A (es) | Derivados 2,3-benzodiazepina y sus usos como inhibidores del receptor-ampa. | |
| NO984740L (no) | Isatinderivater som acetylcholinesteraseinhibitorer og analgetiske midler | |
| PT84823A (en) | Process for the preparation of novel derivatives of 1-substituted imidazoles having dopamine beta-hydroxylase inhibiting pharmacological activity and of pharmaceutical compositions containing the same | |
| NO954576L (no) | AMPA antagonister og en fremgangsmåte til behandling med dem | |
| TW360650B (en) | Pyridin-2-ylmethyloxy-pyridin-5-ylcarbamoyl-indoline derivatives, a process for the preparation thereof, and a pharmaceutical composition comprising them | |
| DE69819166D1 (de) | 8-substituierte-9h-1,3-dioxolo/4,5-h//2,3/benzodiazepin derivate als ampa/kainate-rezeptor-hemmer | |
| WO1998031704A3 (en) | Tachykinin antagonists | |
| ES2149984T3 (es) | Derivados imidazolilalquilos de imidazol(5,1-c)(1,4)benzoxazin-1-ona y su utilizacion como agentes terapeuticos. | |
| AP9801410A0 (en) | Indoline derivatives useful as 5-HT-2C receptor antagonists. | |
| YU60803A (sh) | Upotreba antagonista gal3 receptora u lečenju depresije i/ili uznemirenosti i jedinjenja korisna u tim postupcima | |
| ES2102295A1 (es) | Nuevos compuestos derivados de la n-benzoilmetil-piperidina. | |
| BR9713682A (pt) | Compostos alfa - 1 adrenergicos de benzopiranopirrol e benzopiranopiridina | |
| DE69903930D1 (de) | N-aryloxyethyl-indolyl-alkylamine zur behandlung von depressionen | |
| ATE265453T1 (de) | Diketopiperazinderivate als thrombininhibitoren |